Macular edema due to retinal vein occlusion
Conditions
Interventions
QL1205 group :Domestic Ranibizumab Injection
Lucentis group:Lucentis (Ranibizumab Injection, Imported)
Sponsors
Bengbu Municipal Second People Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who are diagnosed with macular edema due to retinal vein occlusion at our hospital and have not received prior treatment; 2. Both the patients and their family members have given informed consent and are able to complete a one - year follow - up.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of fundus diseases or those who have previously undergone ophthalmic surgical treatment; 2. Patients who are systemically or ocularly unfit for fluorescein fundus angiography (FFA) and intravitreal injection of VEGF inhibitors; 3. Patients with severe abnormalities in vital organs such as the cardiovascular system, liver, and kidneys, and are unable to tolerate ophthalmic examinations and treatments; 4. Poor - quality OCT or OCTA images.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vision; | — |
Secondary
| Measure | Time frame |
|---|---|
| Optical coherence tomography angiography result ;Aqueous humor biomarker ; | — |
Countries
China
Contacts
Public ContactHaiyue Yu
Bengbu Municipal Second People Hospital
Outcome results
None listed